Differential protection with inhibitors of caspase-8 and caspase-3 in murine models of tumor necrosis factor and Fas receptor-mediated hepatocellular apoptosisBAJT, Mary Lynn; VONDERFECHT, Steven L; JAESCHKE, Hartmut et al.Toxicology and applied pharmacology. 2001, Vol 175, Num 3, pp 243-252, issn 0041-008XArticle

Strategic importance of Research support through pathology : Discovery pathology: Compound selection and early developmentCOCKERELL, Gary L; MCKIM, James M; VONDERFECHT, Steven L et al.Toxicologic pathology. 2002, Vol 30, Num 1, pp 4-7, issn 0192-6233Article

Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo : Evidence for a postmitochondrial processing of caspase-8BAJT, Mary Lynn; LAWSON, Judy A; VONDERFECHT, Steven L et al.Toxicological sciences (Print). 2000, Vol 58, Num 1, pp 109-117, issn 1096-6080Article

Nonclinical Safety Evaluation of Sunitinib : A Potent Inhibitor of VEGF, PDGF, KIT, FLT3, and RET ReceptorsPATYNA, Shem; ARRIGONI, Claudio; TERRON, Andrea et al.Toxicologic pathology. 2008, Vol 36, Num 7, pp 905-916, issn 0192-6233, 12 p.Article